Home Features Board Educational Trust Wokhardt Ltd. History of Drugs Oath Opportunities Admission

Cultivating Quality while Nurturing Excellence

Wockhardt is among India’s top five Pharmaceutical and Healthcare group, with sales of over Rs.800 crore and a 5-years compounded annual growth rate of 35%. It is strategically focused on growth and excellence through quality of products and services, increasing investments in R & D and competent scientific and managerial manpower. Wockhardt's Business  Activities include Pharmaceuticals Bulk Activities formulations, IV Fluids, Animal Health’s products, Hospitals, Bio-Agro Products and Medical Nutrition.

 


Bombay Wokhardt Building
Global Player
With a Presence's in 11 countries ,Wockhardt is expanding rapidly into a global player ,with products in over 35 countries .It was the first Pharmaceuticals company in India to receive US FDA approval for both pharmaceuticals Formulations as well as for bulk drugs .since then its Factories and products have been approved by other drug regulatory agencies such as the UK MCA,south African MCC ,Australian TGA ,Canadian HPB ,etc .Recently , Wockhardt entered  Into a strategic alliance with sidmak laboratories inc . one of America top ten generic Wockhardt Pharmaceuticals companies . As per the Agreement ,sidmak will market fifteen Wockhardt products in the united states. Several such agreement for European and other major global market are also underway .

 

A Wide Spectrum of manufacturing Techonology

Wockhardt has eleven manufacturing facilities ,nine of which are located in India

Waluj
Mumbai 
Aurangabad 
Ankeleshwar
Daman
Patalganga
Chennai 
chandigarh
one each in the united kingdom (London) 
and the United state of America .

New Manufacturing facilities are also being created in China. Wockhardt has the widest coverage of manufacturing technology across the entire pharmaceutical industry in India. This includes conventional pharmaceuitals as well as Specialized once such as novel Drug delivery system, corticosteroids and cephalosporins, bulk drugs(including sterile antibiotics),recombinant biotechnology and bio-pharmaceuticals ,large volume parenterals and medical nutrition.

Strong Emphasis on R & D
With an annual R & D outly of over Rs.40 crores and an R & D investment of over Rs .100 crores during the last five years ,Wockhardt has one of India ‘s most advanced research facilities .It employee nearly 250 people in R & D ,with over 100PhDs Wockhardt’s R & D covers all aspects of the business.

1.New Drug Discovery
2.Pharmaceuticals Formulation Development including novel Drug Delivery system
3.Innovation process development for bulk actives using chemical ,fermentation andpeptide synthesis  
   technology
4.bio-technology and Bio-pharmaceuticals
5.Development of new medical nutrition products
6.Clinical Research including pharmacology, toxicology, pharmaceutics and pharmacodynamics.
   Agro chemicals and Bio-Agro products

Wockhardt is one of India’s 60 most valuable companies: a seamless with a team of dedicated people commited to getting the best result, thereby improving the quality of life. Creating a picture of health whose canvas is the world.

Y.B. Chavan College Of Pharmacy and Wockhardt Limited 
-Partners In Creating Excellence

 In  recent  years,  the  All  India  Council for Technical Education New Delhi and the Directorate of Technical  Education has been highlighting the need for making technical courses industry-oriented. Increasingly, emphasis  is  being given to institute-industry interaction. It  is  in this context  that  the  management  of  the  Y.B.  Chavan  College  of Pharmacy   thought   of    entering    into   collaboration   with   Wockhardt,   a pharmaceutical company of international repute, so that the symbiosis can generate the more fruitful results for both, the College and Wockhardt.


Areas of Collaboration


Wokhart Aurangabad

Broadly speaking, there are four areas where the two institutions will work closely together:

 

 

  1. Providing Human Resources for collaborative research n the areas of:

Pre-formulation Study – of physico-chemical properties  of   drugs,   including   drug-drug interaction and recipient interaction, using various instrumental techniques.
Literature Search – for preformulation studies through databases as well as from various pharmaceutical journals.
Clonical Research-creating the base for clinical trials by  providing   both   space  and human volunteers.
   2.   On-the job Training to students during the course of study, so as to enable them to correlate
          the  theoretical background with actual performance in the pharmaceutical industry, in
          various operational areas such as:

I

Manufacturing of various dosage forms, such as tablets, capsules, orals, eye drops, ointments, injectables, etc.
II Chemical and Pharmaceutical Research, so as to conceptualise the functioning of various activities in R & D.
III Quality Assurance / Quality Control, for exposure and hands-on training in the various analytical techniques, documentation validity and regulatory aspects.
    3.   Corporate Image, by way of hypothecating the new laboratories in the College where
          students will get exposure to new instruments and techniques with access to an up-to-date
          library and other equipment, form time to time.
    4.   Technical Expertise forms the industry, within the overall framework. Wockhardt will also  provide facilities such as training the College’s faculty, arranging guest lectures from different disciplines of the pharmaceutical industry; making available its library facility at   the Research Centre to both students and staff members, as well as awarding generous cash prizes to final year students scoring the highest marks in Pharmaceutics. The Trust, on its part, will endeavor to provide at least 20 male volunteers every month to Wockhardt, form the Y.B. Chavan College of  Pharmacy or other colleges at Aurangabad, for carrying out bio-equivalence  studies.Wockhardt will pay the volunteers and take complete medical care of them. The Company will be  responsible for any  consequences   resulting from  these bio-equivalence studies.
Home Features Board Educational Trust Wokhardt Ltd. History of Drugs Oath Opportunities Admission